These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 33967553)

  • 1. Hepatitis C virus micro-elimination: Where do we stand?
    Mangia A; Cotugno R; Cocomazzi G; Squillante MM; Piazzolla V
    World J Gastroenterol; 2021 Apr; 27(16):1728-1737. PubMed ID: 33967553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hepatitis C in a psychiatric setting: A forgotten reservoir?].
    Rolland B; Bailly F; Cutarella C; Drevon O; Carrieri P; Darque A; Hallouche N; Maptue N; Pol S; Llorca PM; Lang JP
    Encephale; 2021 Apr; 47(2):181-184. PubMed ID: 32473777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outreach onsite treatment with a simplified pangenotypic direct-acting anti-viral regimen for hepatitis C virus micro-elimination in a prison.
    Chen CT; Lu MY; Hsieh MH; Tsai PC; Hsieh TY; Yeh ML; Huang CI; Tsai YS; Ko YM; Lin CC; Chen KY; Wei YJ; Hsu PY; Hsu CT; Jang TY; Liu TW; Liang PC; Hsieh MY; Lin ZY; Huang CF; Huang JF; Dai CY; Chuang WL; Shih YL; Yu ML
    World J Gastroenterol; 2022 Jan; 28(2):263-274. PubMed ID: 35110949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined treatment and prevention strategies for hepatitis C virus elimination in the prisons in New South Wales: a modelling study.
    Bretaña NA; Gray RR; Cunningham EB; Betz-Stablein B; Ribeiro R; Graw F; Luciani F; Lloyd AR
    Addiction; 2020 May; 115(5):901-913. PubMed ID: 31633853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Securing wider EU commitment to the elimination of hepatitis C virus.
    Wedemeyer H; Tergast TL; Lazarus JV; Razavi H; Bakoyannis K; Baptista-Leite R; Bartoli M; Bruggmann P; Buşoi CS; Buti M; Carballo M; Castera L; Colombo M; Coutinho RS; Dadon Y; Esmat G; Esteban R; Farran JC; Gillyon-Powell M; Goldberg D; Hutchinson S; Janssen HLA; Kalamitsis G; Kondili LA; Lambert JS; Marinho RT; Maticic M; Patricello A; Peck-Radosavljevic M; Pol S; Poljak M; Pop C; Sokol T; Sypsa V; Tözün N; Younossi Z; Aghemo A; Papatheodoridis GV; Hatzakis A
    Liver Int; 2023 Feb; 43(2):276-291. PubMed ID: 36196744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elimination of HCV in Russia: Barriers and Perspective.
    Isakov V; Nikityuk D
    Viruses; 2022 Apr; 14(4):. PubMed ID: 35458520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Elimination of hepatitis C virus in Denmark].
    Døssing A; Røge BT; Madsen LG; Laursen AL; Hansen JB; Bukh J; Weis N
    Ugeskr Laeger; 2020 Feb; 182(9):. PubMed ID: 32138816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Securing sustainable funding for viral hepatitis elimination plans.
    Hatzakis A; Lazarus JV; Cholongitas E; Baptista-Leite R; Boucher C; Busoi CS; Deuffic-Burban S; Chhatwal J; Esmat G; Hutchinson S; Malliori MM; Maticic M; Mozalevskis A; Negro F; Papandreou GA; Papatheodoridis GV; Peck-Radosavljevic M; Razavi H; Reic T; Schatz E; Tozun N; Younossi Z; Manns MP
    Liver Int; 2020 Feb; 40(2):260-270. PubMed ID: 31808281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is elimination of HCV in 2030 realistic in Central Europe.
    Flisiak R; Zarębska-Michaluk D; Frankova S; Grgurevic I; Hunyady B; Jarcuska P; Kupčinskas L; Makara M; Simonova M; Sperl J; Tolmane I; Vince A
    Liver Int; 2021 Jun; 41 Suppl 1():56-60. PubMed ID: 34155796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased case-finding and uptake of direct-acting antiviral treatment essential for micro-elimination of hepatitis C among people living with HIV: a national record linkage study.
    McLeod A; Hutchinson SJ; Smith S; Leen C; Clifford S; McAuley A; Wallace LA; Barclay ST; Bramley P; Dillon JF; Fraser A; Gunson RN; Hayes PC; Kennedy N; Peters E; Templeton K; Goldberg DJ
    HIV Med; 2021 May; 22(5):334-345. PubMed ID: 33350049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus micro-elimination in people who inject drugs: Challenges and chance in Taiwan and worldwide.
    Tai CM; Yu ML
    Kaohsiung J Med Sci; 2024 Feb; 40(2):112-118. PubMed ID: 38010851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress on global hepatitis elimination targets.
    Waheed Y
    World J Gastroenterol; 2021 Dec; 27(47):8199-8200. PubMed ID: 35068864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C screening in Lithuania: first-year results and scenarios for achieving WHO elimination targets.
    Petkevičienė J; Voeller A; Čiupkevičienė E; Razavi-Shearer D; Liakina V; Jančorienė L; Kazėnaitė E; Zaksas V; Urbonas G; Kupčinskas L
    BMC Public Health; 2024 Apr; 24(1):1055. PubMed ID: 38622549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collaborative Referral Model to Achieve Hepatitis C Micro-Elimination in Methadone Maintenance Treatment Patients during the COVID-19 Pandemic.
    Tai CM; Huang CK; Changchien TC; Lin PC; Wang DW; Chang TT; Chan HW; Chen TH; Tseng CH; Chen CC; Tsai CT; Sie YT; Yen YC; Yu ML
    Viruses; 2022 Jul; 14(8):. PubMed ID: 35893702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating people where they are: Nurse-led micro-elimination of hepatitis C in supported housing sites for networks of people who inject drugs in Victoria, Canada.
    Selfridge M; Barnett T; Lundgren K; Guarasci K; Milne R; Drost A; Fraser C
    Public Health Nurs; 2022 Sep; 39(5):1009-1016. PubMed ID: 35537120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is elimination of hepatitis C virus realistic by 2030: Eastern Europe.
    Isakov V; Tsyrkunov V; Nikityuk D
    Liver Int; 2021 Jun; 41 Suppl 1():50-55. PubMed ID: 34155800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Treatment-as-Prevention Trial to Eliminate Hepatitis C Among Men Who Have Sex With Men Living With Human Immunodeficiency Virus (HIV) in the Swiss HIV Cohort Study.
    Braun DL; Hampel B; Ledergerber B; Grube C; Nguyen H; Künzler-Heule P; Shah C; Salazar-Vizcaya L; Conen A; Flepp M; Stöckle M; Béguelin C; Schmid P; Rougemont M; Delaloye J; Bernasconi E; Nicca D; Böni J; Rauch A; Kouyos RD; Günthard HF; Fehr JS
    Clin Infect Dis; 2021 Oct; 73(7):e2194-e2202. PubMed ID: 32761122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Coronavirus Disease 2019 Pandemic on Viral Hepatitis Elimination: What Is the Price?
    Sowah L; Chiou C
    AIDS Res Hum Retroviruses; 2021 Aug; 37(8):585-588. PubMed ID: 33913731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic viral hepatitis C micro-elimination program using telemedicine. The Mexican experience.
    Pérez Hernández JL; Higuera de la Tijera MF; Arce Salinas CA
    Rev Esp Enferm Dig; 2021 Aug; 113(8):624-625. PubMed ID: 33569965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C: The beginning of the end-key elements for successful European and national strategies to eliminate HCV in Europe.
    Papatheodoridis GV; Hatzakis A; Cholongitas E; Baptista-Leite R; Baskozos I; Chhatwal J; Colombo M; Cortez-Pinto H; Craxi A; Goldberg D; Gore C; Kautz A; Lazarus JV; Mendão L; Peck-Radosavljevic M; Razavi H; Schatz E; Tözün N; van Damme P; Wedemeyer H; Yazdanpanah Y; Zuure F; Manns MP
    J Viral Hepat; 2018 Mar; 25 Suppl 1():6-17. PubMed ID: 29508946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.